[1]GBD 2019 Stroke Collaborators. Global，regional，and national burden of stroke and its risk factors，1990-2019：a systematic analysis for the global burden of disease study 2019[J]. Lancet Neurol，2021，20（10）：795-820.
[2]王拥军，李子孝，谷鸿秋，等. 中国卒中报告2020（中文版）（1）[J]. 中国卒中杂志，2022，17（5）：433-447.
[3]FALCONE G J，MALIK R，DICHGANS M，et al. Current concepts and clinical applications of stroke genetics[J]. Lancet Neurol，2014，13（4）：405-418.
[4]DEVAN W J，FALCONE G J，ANDERSON C D，et al. Heritability estimates identify a substantial genetic contribution to risk and outcome of intracerebral hemorrhage[J]. Stroke，2013，44（6）：1578-1583.
[5]BEVAN S，TRAYLOR M，ADIB-SAMII P，et al. Genetic heritability of ischemic stroke and the contribution of previously reported candidate gene and genomewide associations[J]. Stroke，2012，43（12）：3161-3167.
[6]PSATY B M，O’DONNELL C J，GUDNASON V，et al. Cohorts for heart and aging research in genomic epidemiology（CHARGE） consortium：design of prospective meta-analyses of genome-wide association studies from 5 cohorts[J]. Circ Cardiovasc Genet，2009，2（1）：73-80.
[7]GRETARSDOTTIR S，THORLEIFSSON G，MANOLESCU A，et al. Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke[J]. Ann Neurol，2008，64（4）：402-409.
[8]MISHRA A，MALIK R，HACHIYA T，et al. Stroke genetics informs drug discovery and risk prediction across ancestries[J]. Nature，2022，611（7934）：115-123.
[9]MALIK R，CHAUHAN G，TRAYLOR M，et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes[J]. Nat Genet，2018，50（4）：524-537.
[10]ZHOU M，WANG H，ZENG X，et al. Mortality，morbidity，and risk factors in China and its provinces，1990-2017：a systematic analysis for the global burden of disease study 2017[J]. Lancet，2019，394（10204）：1145-1158.
[11]OKAZAKI S，MORIMOTO T，KAMATANI Y，et al. Moyamoya disease susceptibility variant RNF213 p.R4810K increases the risk of ischemic stroke attributable to large-artery atherosclerosis[J]. Circulation，2019，139（2）：295-298.
[12]ZHU Z H，ZHANG F T，HU H，et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets[J]. Nat Genet，2016，48（5）：481-487.
[13]MONTANER J，RAMIRO L，SIMATS A，et al. Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke[J]. Nat Rev Neurol，2020，16（5）：247-264.
[14]GUSEV A，KO A，SHI H，et al. Integrative approaches for large-scale transcriptome-wide association studies[J]. Nat Genet，2016，48（3）：245-252.
[15]GIAMBARTOLOMEI C，VUKCEVIC D，SCHADT E E，et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics[J/OL]. PLoS Genet，2014，10（5）：e1004383[2022-12-12]. https://doi.org/10.1371/journal.pgen.1004383.
[16]TRAYLOR M，PERSYN E，TOMPPO L，et al. Genetic basis of lacunar stroke：a pooled analysis of individual patient data and genome-wide association studies[J]. Lancet Neurol，2021，20（5）：351-361.
[17]LIU M，XU P，GUAN Z L，et al. Ulk4 deficiency leads to hypomyelination in mice[J]. Glia，2018，66（1）：175-190.
[18]BINDESBØLL C，AAS A，OGMUNDSDOTTIR M H，et al. NBEAL1 controls SREBP2 processing and cholesterol metabolism and is a susceptibility locus for coronary artery disease[J/OL]. Sci Rep，2020，10（1）：4528[2022-12-12]. https://doi.org/10.1038/s41598-020-61352-0.
[19]YANG C，FARIAS F H G，IBANEZ L，et al. Genomic atlas of the proteome from brain，CSF and plasma prioritizes proteins implicated in neurological disorders[J]. Nat Neurosci，2021，24（9）：1302-1312.
[20]AZGHANDI S，PRELL C，VAN DER LAAN S W，et al. Deficiency of the stroke relevant HDAC9 gene attenuates atherosclerosis in accord with allele-specific effects at 7p21.1[J]. Stroke，2015，46（1）：197-202.
[21]ASARE Y，CAMPBELL-JAMES T A，BOKOV Y，et al. Histone deacetylase 9 activates ikk to regulate atherosclerotic plaque vulnerability[J]. Circ Res，2020，127（6）：811-823.
[22]NELSON M R，TIPNEY H，PAINTER J L，et al. The support of human genetic evidence for approved drug indications[J]. Nat Genet，2015，47（8）：856-860.
[23]GEORGAKIS M K，MALIK R，ANDERSON C D，et al. Genetic determinants of blood lipids and cerebral small vessel disease：role of high-density lipoprotein cholesterol[J]. Brain，2020，143（2）：597-610.
[24]NAMBA S，KONUMA T，WU K H，et al. A practical guideline of genomics-driven drug discovery in the era of global biobank meta-analysis[J/OL]. Cell Genom，2022,2（10）：100190[2022-12-12]. https://doi.org/10.1016/j.xgen.2022.100190.
[25]GEORGAKIS M K，MALIK R，BJÖRKBACKA H，et al. Circulating monocyte chemoattractant protein-1 and risk of stroke：meta-analysis of population-based studies involving 17 180 individuals[J]. Circ Res，2019，125（8）：773-782.
[26]SMITH G D，EBRAHIM S. “Mendelian randomization”：can genetic epidemiology contribute to understanding environmental determinants of disease?[J]. Int J Epidemiol，2003，32（1）：1-22.
[27]PIERCE B L，AHSAN H，VANDERWEELE T J. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants[J]. Int J Epidemiol，2011，40（3）：740-752.
[28]XU J，WANG A X，WANGQIN R Q，et al. Efficacy of clopidogrel for stroke depends on CYP2C19 genotype and risk profile[J]. Ann Neurol，2019，86（3）：419-426.
[29]WANG Y J，MENG X，WANG A X，et al. Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA[J]. N Engl J Med，2021，385（27）：2520-2530.
[30]ABRAHAM G，INOUYE M. Genomic risk prediction of complex human disease and its clinical application[J/OL]. Curr Opin Genet Dev，2015，33：10-16[2022-12-12]. https://doi.org/10.1016/j.gde.2015.06.005.
[31]LAMBERT S A，ABRAHAM G，INOUYE M. Towards clinical utility of polygenic risk scores[J/OL]. Hum Mol Genet，2019，28（R2）：R133-R142[2022-12-12]. https://doi.org/10.1093/hmg/ddz187.
[32]KHERA A V，CHAFFIN M，ARAGAM K G，et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations[J]. Nat Genet，2018，50（9）：1219-1224.
[33]KHERA A V，EMDIN C A，DRAKE I，et al. Genetic risk，adherence to a healthy lifestyle，and coronary disease[J]. N Engl J Med，2016，375（24）：2349-2358.
[34]CHENG S，XU Z，LIU Y，et al. Whole genome sequencing of 10K patients with acute ischaemic stroke or transient ischaemic attack：design，methods and baseline patient characteristics[J]. Stroke Vasc Neurol，2021，6（2）：291-297.
